Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Cyclerion Therapeutics Inc’s current trading price is -57.90% away from its 52-week high, while its distance from the 52-week low is 29.24%. The stock’s price range over this period has fluctuated between $1.71 and $5.25. The company, operating within the financial sector, had a trading volume of approximately 2.11 million for the day, which was noticeably higher than the average daily share volume of 16090.0 over the last 3 months.
Cyclerion Therapeutics Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $5.25 on 12/19/23 and a low of $1.71 for the same time frame on 11/14/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Cyclerion Therapeutics Inc (CYCN) has experienced a quarterly decline of -11.95% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.99M and boasts a workforce of 1 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.8005, with a change in price of -0.6100. Similarly, Cyclerion Therapeutics Inc recorded 25,960 in trading volume during the last 100 days, posting a change of -21.25%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CYCN stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
CYCN Stock Stochastic Average
Today, Cyclerion Therapeutics Inc’s raw stochastic average for the past 50 days stands at 22.73%, indicating a rise from the raw stochastic average of the last 20 days, which was 22.73%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 9.64% and 8.39% respectively.
CYCN Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Year to date metric has recorded a loss of -34.03%.However, over the last six months, we can see a stronger performance of -22.18%. Over the last 30 days, the price of CYCN has leaped by -7.92%. And in the last five days, it has fallen by -12.65%.
